PD-L1 peptide
MY18H2
Phase 2 mab terminated
Quick answer
PD-L1 peptide for Smoldering Multiple Myeloma is a Phase 2 program (mab) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Smoldering Multiple Myeloma
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated